Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.
about
Hydrogel: Preparation, characterization, and applications: A reviewMicro/nanofabricated platforms for oral drug deliveryDevelopment of Novel Oral Formulations Prepared via Hot Melt Extrusion for Targeted Delivery of Photosensitizer to the ColonIn-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil.Colorectal cancer targeted Irinotecan-Assam Bora rice starch based microspheres: a mechanistic, pharmacokinetic and biochemical investigation.Cytotoxicity and antitumour activity of 5-fluorouracil-loaded polyhydroxybutyrate and cellulose acetate phthalate blend microspheres.In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-crosslinked chitosan microspheres in colorectal cancer therapy in rats.In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats.Development of pH- and enzyme-controlled, colon-targeted, pulsed delivery system of a poorly water-soluble drug: preparation and in vitro evaluation.A composite polyelectrolytic matrix for controlled oral drug delivery.Pectin matrix as oral drug delivery vehicle for colon cancer treatmentColon-targeted quercetin delivery using natural polymer to enhance its bioavailability.Colon targeted delivery systems: review of polysaccharides for encapsulation and delivery.Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting.Pectin-based oral drug delivery to the colon.In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.Methacrylic-based nanogels for the pH-sensitive delivery of 5-fluorouracil in the colonColon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES) in multi-pH media using United States Pharmacopeia apparatus II and IIIMultiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease.Polysaccharides: a targeting strategy for colonic drug delivery.Colon targeted drug delivery systems: a review on primary and novel approaches.Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.Dissolution testing of oral modified-release dosage forms.New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities.A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation.Classification of stimuli-responsive polymers as anticancer drug delivery systems.Probiotic Formulations: Application and Status as Pharmaceuticals-A Review.In Vitro and In Vivo Correlation of Colon-Targeted Compression-Coated Tablets.Coated chitosan nanoparticles encapsulating caspase 3 activator for effective treatment of colorectral cancer.Cytotoxicity of lapachol metabolites produced by probiotics.A novel dissolution media for testing drug release from a nanostructured polysaccharide-based colon specific drug delivery system: an approach to alternative colon media.Development of solid nanoparticles based on hydroxypropyl-β-cyclodextrin aimed for the colonic transmucosal delivery of diclofenac sodium.Development of novel budesonide pellets based on CODES(TM) technology: In vitro/in vivo evaluation in induced colitis in rats.Novel colon targeted drug delivery system using natural polymers.Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery systemComparison of sequential drug release in vitro and in vivo.Proof-of-concept study on the suitability of 13C-urea as a marker substance for assessment of in vivo behaviour of oral colon-targeted dosage forms.Formulation, evaluation and optimization of pectin- bora rice beads for colon targeted drug delivery system.Assessment of isomalt for colon-specific delivery and its comparison with lactulose.
P2860
Q28081281-DB6617AF-1752-49C3-A894-97CACAFCB0FAQ28083448-4A4BC0C3-741D-419D-8EBC-80CE9A2E4104Q29305365-0078E43E-8B75-4E47-BDD2-28BD8A9FF5A4Q33379292-98BE7D66-4C1F-4076-8347-B67BC2B5898EQ33403536-386A9DC2-4D07-4E84-A4D7-07EA29613C06Q33403892-F3B5049B-80C6-4C74-878B-F53F15E6B7DFQ33426108-7BF84511-192F-4376-9908-AB6E2F807FDDQ33427286-77E063D3-95E8-4200-B174-88AC5526FF8DQ33488313-B358B566-C8F7-4C8B-85AA-51454DC914C2Q34733839-DF0F4E60-5803-4CBC-9286-3BC48DAF0F2CQ34733868-9F86C94C-A086-451B-B644-A0E672A6F782Q35057543-BF62A710-112E-4C1A-AD20-FD48680B43E2Q36209061-3CFEAFD7-2E4C-460D-B5AF-B245236AC4D7Q36309011-A5416516-4483-4EE8-B148-A3AC22AA2A91Q36316760-ABA33912-F3DF-439B-8C8C-9C6ABD538F88Q36337331-57126AAD-333F-42A0-B58C-6C903138CB4CQ36410956-5E2CE2E7-F290-45B5-A00E-23B72F7713A2Q37290683-EDAF8541-CAA4-42E7-B600-210D7D1C7C06Q37361828-CDEDA39C-6DE3-4DE9-A0CB-F5DA510B20D7Q37854596-D67C8BA1-8208-412F-9BE2-FB3DF8A94498Q37867127-34D6238B-5EC6-458A-9070-8BADE132395FQ37962516-3670D1A7-6C73-491D-8CF0-1DB590CB1077Q38017299-BBEC44F6-0277-485D-AC22-173B774705B0Q38017706-C550C052-4E85-4E8B-93C6-B9CCD82D6666Q38110619-59CF9C44-AE6A-4D1A-9533-3CD66F893F2FQ38162148-F2AA08DE-18C4-4E37-8E8F-A3D92469F4CDQ38189091-E1F1284A-4895-450D-8ADF-FF431F41CE2DQ38702214-840CD167-5EFB-499A-92F9-D6369E5F4E66Q38708851-759F1305-F9B7-40B7-B925-5C10245FD9DBQ38838402-92A4B98B-5281-44AF-9404-A196D77C2145Q39014789-06FBD7A1-C1DE-4FC9-8FEC-8A87C1930FADQ39344860-8718CAB2-A9D8-404B-98A1-18D7505C6AC8Q39576550-890D730A-A658-4CFC-9D27-7B2E32820C73Q39642034-C8014CDC-889E-4A5B-92AF-3E00EA496C2FQ39962615-5A9F8834-DEA2-4E91-831A-7A1355FFD3C2Q40431750-7BF450CF-3564-4028-8284-B42DEAA81FFFQ40797234-322C6EF6-22FA-4DA1-8CED-EF65D7F5CAE5Q41825771-69434855-FFE4-4194-92AC-6F1559057A72Q41875086-FA556A03-B5BF-4730-8294-54D0D349BB99Q41881682-C186CE46-2ADA-4C9A-A850-05DE4D09C288
P2860
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.
@ast
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.
@en
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.
@nl
type
label
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.
@ast
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.
@en
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.
@nl
prefLabel
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.
@ast
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.
@en
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.
@nl
P2093
P1476
Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation.
@en
P2093
James S Chu
Joseph A Fix
P356
10.1016/S0378-5173(02)00004-2
P407
P577
2002-03-01T00:00:00Z